EPRX TSX · Healthcare · FY 2025-12-31

Eupraxia Pharmaceuticals Inc.

Back to TSX
0.01.73.45.26.9ABVfair 1.55buy ≤ 0.54EPVnot valid for this companyEBVnot valid for this companyDBVnot valid for this companyprice 6.38 USD
0.02.44.87.39.7ABVfair 2.18buy ≤ 0.76EPVnot valid for this companyEBVnot valid for this companyDBVnot valid for this companyprice 8.98 CAD
ABV EPV EBV DBV fair value / share buy at or below (margin of safety applied) margin-of-safety band current price values in USDCAD
Verdict
Avoid
Buy zone
Overvalued
Archetype
Distressed/Deficit
Confidence
●○○ Low · 1/4
Price
6.3798.980 USDCAD *
Market cap
331.3M466.4M USDCAD *
P / B
4.04
P / E
—
EPS
-1.030-1.450
DPS / yield
— (0.0%)
NAV / share
1.5492.180
Graham number
—
Z'' score
11.73
Piotroski F
3 / 9
Beneish M
—
ROIC vs WACC
-2151.2% vs 14.2%

* Listed in CAD — the pipeline states price and all valuations in the filing currency USD (fx 0.71 USD/CAD).

See the full orchestrator pipeline — solvency gate, lens cascade, reconciliation, archetype, decision, and confidence.

Subscribe to unlock this and every other tab for every company.

See the full ABV lens breakdown — gates, steps, and verdict.

Subscribe to unlock this and every other tab for every company.

See the full EPV lens breakdown — gates, steps, and verdict.

Subscribe to unlock this and every other tab for every company.

See the full EBV lens breakdown — gates, steps, and verdict.

Subscribe to unlock this and every other tab for every company.

See the full DBV lens breakdown — gates, steps, and verdict.

Subscribe to unlock this and every other tab for every company.